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Ischaemia/reperfusion (I/R) injury is commonly seen in the field of intestine surgi-
cal interventions, shock, trauma, and many other clinical conditions. Simvastatin
is known to have antioxidant and anti-inflammatory properties. This study inves-
tigated the effect of simvastatin administration in a warm intestinal I/R model on
TNF-a, antioxidant enzymes and intestinal tissue morphology.
Thirty-six male wistar rats underwent laparotomy under general anaesthesia. Sim-
vastatin was administered from four days before ischaemia induction. The
rats were divided in to three groups (n = 12): the sham goup, the I/R group, and
the I/R + simvastatin group. Intestinal ischaemia was induced by superior me-
senteric artery ligation with microvascular clamps for 60 minutes, and after is-
chaemia, blood perfusion was released into the tissue and a reperfusion phase
was started, which lasted for 3 hours. After 3 hours, the animals were sacrificed
and serum and tissue obtained for biochemical and histological study.
In the simvastatin treated group, intestinal tissue injury, TNF-a level, and tissue
malondealdehyde levels were significantly lower than in the I/R group (p < 0.05).
Glutathion peroxidase and superoxide dismutase levels were significantly higher
in the simvastatin treated group than in the I/R group (p < 0.05).
Simvastatin pretreatment reduced intestinal I/R injury and was associated with down-
-regulation of serum TNF-a and tissue malondealdehyde level, and simvastatin
administration maintained cellular antioxidant enzyme contents compared to the
I/R group after 3 hours reperfusion time. (Folia Morphol 2009; 68, 3: 156–162)
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INTRODUCTION
Ischaemia/reperfusion (I/R) injury in the intestine
occurs when the intestinal tissue is deprived of oxy-
gen and other nutrients necessary to maintain cel-
lular function. Mesenteric ischaemia is a clinical en-
tity with a mortality rate between 60% and 100%
that usually requires surgical resection of the necrotic
intestinal segment [4, 9].
It is a well-known phenomenon that reperfusion
is as dangerous for tissues as ischaemia, particularly
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in the heart and the intestines. Intestinal ischaemia
is a result of systemic factors (hypovolaemia, hypoten-
sion, hypoxia, or sepsis) or local factors (cardiopul-
monary by-pass, organ transplantations, abdominal
aortic aneurysm repair, embolectomy for acute me-
senteric occlusion, or repair of traumatic vascular la-
cerations). It can lead to life-threatening complications
associated with remote organ injury [14, 51]. Restored
circulation results in the formation of free oxygen
radicals and other acute phase reactants. Cellular
death occurs via the lipid peroxidation of the cell wall
[14]. The consequences of mesenteric ischaemia are
devastating to patients and usually result in diarrhoea,
malabsorption, short bowel syndrome, and even
death [1]. In addition, I/R injury has been a key prob-
lem with respect to successful organ preservation in
small intestine transplantation [33].
The gastrointestinal tract is one of the most sen-
sitive organs to ischaemia and reperfusion [30]. Thus,
there is great interest concerning methods to verify
protective mechanisms in extensive small intestine
lesions that can shorten the patient’s life. For effec-
tive transplantation treatment, we must identify and
protect small intestine morphological changes af-
ter I/R injury. In this regard, many authors have stud-
ied small intestine morphological aspects to deter-
mine what might correlate to the pathogenesis of
the resulting injury and protective mechanisms [11, 19].
Although there have been advancements in the
treatment of ischaemic injury, an ideal treatment
has not been defined, and new options should be
considered.
The mechanisms of intestinal mucosa injury af-
ter intestinal I/R are complex. Reactive oxygen spe-
cies (ROS)-induced lipid peroxidation is known to
be one of the major factors causing intestinal I/R
injury, and the administration of free radical scav-
engers appears to prevent intestinal mucosa from
intestinal I/R injury [27, 42]. During reperfusion, re-
introduction of molecular oxygen into the ischaem-
ic tissue results in the production of ROS such as
superoxide anion, hydrogen peroxide, peroxinitrite,
and hydroxyl radicals [11], particularly, hydroxyl rad-
icals typically cause biological damage by stimulat-
ing the free chain reaction known as lipid peroxida-
tion [5, 44, 46].
Inflammatory pathways play an important role
in pathogenesis of intestinal I/R, through produc-
tion of inflammatory cytokines, involvement of the
complement system, and neutrophil infiltration
[4, 9, 14, 30, 33, 42] at the site of damage [5, 18,
24, 28, 29, 41].
3-hydroxy-3-methylglutaryl coenzyme A (HMG-
-CoA) reductase inhibitors, or statins, are a class of
drugs particularly beneficial in combating this risk fac-
tor. Therapeutic doses of statins potently reduce se-
rum cholesterol levels in humans [40]. They have been
shown to have properties independent of their cho-
lesterol-lowering ability, referred to as pleiotropic ef-
fects. It has been shown that pretreatment with st-
atins decreases tumour necrosis factor alpha (TNF-a)
production [21, 38, 49] and enhances superoxide dis-
mutase (SOD) levels [6, 54]. It is effective in prevent-
ing reperfusion injury after I/R in experimental models
of I/R in the liver [12], heart [43] and kidneys [52].
The current study was performed to clarify
whether simvastatin can prevent intestinal mucosa
I/R injury and tissue anti-oxidant enzyme content,
and to investigate its effects on TNF-a release dur-
ing intestinal I/R in an in vivo rat model.
MATERIAL AND METHODS
Surgical procedure
The study was carried out with 36 male Wistar
rats (purchased from the central animal house of
Tabriz medical school, Tabriz, Iran) weighing be-
tween 220 and 260 g. The rats were kept at room
temperature and provided with free access to stan-
dard chow and tap water. This research was done
in accordance with university guidelines for the care
of laboratory animals.
Under ketamine (50 mg/kg) and xylazine (10 mg/kg)
anaesthesia, a median laparotomy was performed
and the blood supply to the intestine was interrupt-
ed for 60 minutes by occlusion of the superior me-
senteric artery using a microvascular clamp. Intesti-
nal ischaemia was confirmed by observing the loss
of pulsation of the mesenteric artery and its branch-
es, as well as paleness of the jejunum and ileum.
Afterwards the intestines were returned to the ab-
domen, which was then closed with two small
clamps. At the end of 60 minutes of ischaemia, the
clamp was gently removed to allow reperfusion of
the blood flow for 3 hours, which was confirmed by
observing the pulsation of the artery and its branches
on the intestine [36].
Experimental design
The rats were divided into three groups of twelve
animals as follows:
— sham operation (sham) group (n = 12): animals
were subjected to laparotomy without vascular
occlusion;
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moderate lifting of the epithelial layer from the
lamina propria;
— grade 3 — massive epithelial lifting down the
side of the villi and a few tips may be denuded;
— grade 4 — denuded villi with lamina propria and
dilated capillaries exposed;
— grade 5 — digestion and disintegration of lami-
na propria, haemorrhage, and ulceration [17].
Elisa assay for TNF-a
Plasma levels of TNF-a were measured by an en-
zyme-linked immunoabsorbent assay (ELISA) using
a rat TNF-a immunoassay kit (Blender systems, Aus-
tria).
Statistical analysis
Data were analyzed using SPSS software 13. All
data are reported as mean ± SD. Statistical com-
parisons of the groups were performed by one-way
ANOVA analysis of variance followed by Tukey post-
test. P < 0.05 was considered significant.
RESULTS
GPx and SOD
GPx and SOD levels in the intestinal I/R group
were lower in comparison to the sham group and
the intestinal I/R +simvastatin group, while the le-
vels of these enzymes were significantly lower in the
I/R + simvastatin group compared to the sham
group (p < 0.05, Table 1).
MDA
Intestinal I/R increased intestinal tissue MDA lev-
els, and it was higher in the intestinal I/R group com-
pared to the other groups, and the MDA levels in
the intestinal I/R + simvastatin group was signifi-
cantly higher than in the sham group (p < 0.05,
Table 1).
TNF-a
At 3 hours post intestinal I/R, the serum TNF-a
level was significantly increased compared to the
sham group. Serum TNF-a level was significantly lower
in the intestinal I/R + simvastatin group compared
to the intestinal I/R group (p < 0.05, Table 1).
Histological assessment
One hour intestinal ischaemia followed by
3 hours reperfusion resulted in the development of
subepithelial space at the apex of the villous and
capillary congestion, extension of the subepithelial
space with moderate lifting of the epithelial layer
— ischaemia/reperfusion (I/R) group (n = 12): ani-
mals were subjected to 60 minutes of intestinal
ischaemia and sacrificed 3 hours after reperfusion;
— ischemia/reperfusion + simvastatin (I/R + simvas-
tatin) group (n = 12): as in the I/R group, but also
treated with simvastatin (10 mg/kg/day) adminis-
tered orally since 4 days before I/R induction.
At the time of sacrifice, under anaesthesia,
venous blood samples were obtained for serum TNF-a
level, then a laparotomy was performed and the in-
testine was removed. Intestinal tissue samples were
obtained and frozen at –70°C for measurement of
glutathione peroxidase (GPx), SOD, and malondial-
dehyde (MDA). Intestine samples were also fixed in
buffer formalin for histological analysis.
GPx assay
For tissue biochemical analysis, the intestinal tis-
sue was homogenized in 1.15 KCL solution. GPx
measurements were performed as described by Pa-
glia et al. [37]. GPx was catalyzed by the oxidation
of reduced glutathione in the presence of cumene
hydroxyperoxide. GPx activity was designated as unit
for mg/protein of intestinal tissue.
SOD assay
SOD activity was determined as described by Sun
et al. [50]. This method depends on the inhibition
of nitroblue tetrazolium (NBT) reduction by xanthine-
-xanthine oxidase used as a superoxide generator.
SOD activity was expressed as the amount of en-
zyme that causes 50% inhibition of the rate of NBT
reduction. SOD activity was designated as unit for
mg/protein of intestinal tissue.
Serum MDA measurement
Serum MDA levels were studied using thiobarbi-
turic acid (TBA), as described previously [23, 55].
Histological assessment
Formalin-fixed and paraffin-embedded tissue
sections were cut at 5 mm and stained with haema-
toxylin and eosin for histological examination. Light
microscopy was used to assess the degree of intes-
tinal tissue damage, which was performed by a pa-
thologist who was blinded to the treatment given.
Tissue samples were scored by using the following
grading scale:
— grade 0 — normal mucosa;
— grade 1 — development of subepithelial space at
the apex of the villous and capillary congestion;
— grade 2 –– extension of subepithelial space with
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from the lamina propria, massive epithelial lifting
down the side of the villi, and denuded villi with
lamina propria and dilated capillaries exposed, di-
gestion and disintegration of lamina propria, and
haemorrhage and ulceration in the intestinal tissue.
The grade of tissue injury in the intestinal I/R + sim-
vastatin group was significantly lower than in the
intestinal I/R group (p < 0.05, Table 2).
DISCUSSION
In the present study, we demonstrated that sim-
vastatin suppressed pro-inflammatory cytokine TNF-a
levels in plasma of rats undergoing intestinal I/R.
The histological study revealed severe intestinal
mucosal damage, suppressed GPx and SOD levels,
and increased MDA levels in the I/R animals; how-
ever, these findings were significantly ameliorated
in the simvastatin treated animals. The small intes-
tine is extremely sensitive to ischaemic insult, and in
some clinical circumstances gives rise to mesenteric
hypoperfusion followed by I/R injury. Despite the ex-
istence of evidence detailing the pathogenesis of the
intestinal I/R injury, the exact mechanism of this com-
plex process is still unknown [44]. Intestinal I/R inju-
ry occurs in a biphasic manner characterized by dif-
ferent time frames and mechanisms: (1) an early
phase that immediately follows the transient is-
chaemia and lasts 2 to 3 hours; and (2) a late phase
which begins 12 to 24 hours from the transient is-
chaemia and lasts for about 3 to 4 days [29, 51]. In
our study, a period of 60 minutes of ischaemia fol-
lowing 3 hours of reperfusion was especially cho-
sen to assess the changes in the early phase of re-
perfusion injury, which is in a clinically relevant time
frame. The alterations in intestinal motility caused
by I/R are directly related to the length of both is-
chaemia and reperfusion time [39]. The functional
alterations caused by I/R have been previously iden-
tified [31]. These changes consist of reversible alter-
ations in smooth muscle contractility and intestinal
transit, as well as characteristic changes in electrical
activity during ischaemia [2, 25]. The structural dam-
age caused by ischaemia is aggravated by the resti-
tution of blood flow. The physiopathology of intes-
tinal mucosal damage by I/R is not completely un-
derstood. Nevertheless, it is believed that cytotoxic
substances such as free radicals, nitric oxide, sero-
tonin, and complement, as well as neutrophil infil-
tration and nuclear transcription factors, play im-
portant roles [7]. Macrophages have been also im-
plicated in the initial damage caused by intestinal
I/R [10]. I/R has also been shown to induce apopto-
sis [35]. Bacterial translocation and mucosal barrier
dysfunction have been implicated in the damage
caused by I/R in the gut [4, 8, 20]. I/R injury causes
maldistribution of blood flow, damage to endothe-
lium, coagulation abnormalities, and aggregation
of platelets and neutrophils. The activation of neu-
trophils leads to the release of ROS including super-
oxide anion (O2–) and H2O2. A growing amount of
circumstantial evidence implicates oxygen-derived
free radicals (especially O2– and H2O2) and high-
Table 1. The effect of simvastatin on intestinal antioxidant enzyme content, MDA level and serum TNF-a in the rat
intestine after ischaemia and reperfusion
Sham Intestinal I/R Intestinal I/R + simvastatin
GPx [U/mg protein] 3.60 ± 0.45 1.93 ± 0.17 2.96 ± 0.24
SOD [U/mg protein] 2.56 ± 0.62 0.94 ± 0.37 1.78 ± 0.27
MDA [nmol/mL] 1.64 ± 0.34 3.90 ± 0.54 2.72 ± 0.28
TNF-a [pg/mL] 23 ± 5.05 95 ± 15.70 72.14 ± 16.02
The rat intestine was pretreated with simvastatin prior to ischaemia; intestine was subjected to 60 minutes ischaemia followed by 3 hours of reperfusion. The values are
shown as a mean ±SD for rats in each group and a difference of (p < 0.05) was considered significant; GPx — glutathione peroxidase, SOD — superoxide dismutase,
MDA — malondialdehyde, TNF-a — tumour necrosis factor alpha
Table 2. The effect of simvastatin on intestinal tissue injury index after ischaemia/reperfusion
Sham Intestinal I/R Intestinal I/R + simvastatin
Intestinal tissue injury index 0.66 ± 0.51 4.16 ± 0.75 3.14 ± 0.69
The rat intestine was pretreated with simvastatin prior to ischaemia; intestine was subjected to 60 minutes ischaemia followed by 3 hours of reperfusion. The values are
shown as a mean ±SD for rats in each group and a difference of (p < 0.05) was considered significant.
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-energy oxidants (e.g., peroxynitrite, ONOO–) as me-
diators of I/R injury [57]. It has been shown that the
toxicity ascribed to the O2– is initially caused by the
superoxide’s direct or indirect interaction with bio-
logical targets such as lipids, catecholamines, and
DNA. Moreover, simultaneous generation of nitric
oxide (NO) and O2– favours the production of a toxic
reaction product, ONOO–, and this product may ac-
count for some of the deleterious effects associated
with NO production [26]. Therapeutic strategies
aimed at ameliorating I/R damage include antioxi-
dant enzymes such as SOD and GPx, free radical scav-
engers such as mannitol and a-tocopherol, and
agents which prevent the generation of radicals such
as allopurinol and deferoxamine. Because of the sig-
nificant role played by oxygen-derived free radicals
in the pathogenesis of I/R, studies on the applica-
tion of free oxygen radical scavengers to limit the
damage to tissue and organs have been attempted
[32, 51]. What is more, in this study, we aimed to
investigate whether simvastatin can be effective in
preventing the reperfusion injury of intestinal dam-
age after 60 minutes of warm superior mesenteric
ischaemia in rats. We examined organ GPx and SOD
levels as markers of antioxidative function. GPx and
SOD reduce oxidative stress resulting from gut I/R
and prevent tissue injury [3, 16]. However, in the
present study, simvastatin treatment improved small
intestinal GPx and SOD levels within our experimen-
tal time frame. Modulation of the inflammatory re-
sponse following I/R injury is an important compo-
nent of tissue defence, mostly because inflamma-
tion is the major component of cell death and motor
alteration in intestine subjected to intestinal injury.
Lipid peroxidation results from the reaction of
reactive oxygen metabolites, especially the hydroxyl
and hydroperoxyl radicals with the membrane bound
polyunsaturated fatty acids with a loss of a carbon
radical and its rearrangement for formation of
a conjugated diene. This conjugated form reacts im-
mediately with oxygen to form peroxide radicals.
Peroxide radicals initiate a chain reaction by remov-
ing a hydrogen atom from the other fatty acids. The
product of this reaction is tissue MDA and hydro-
peroxide [34]; in this study simvastatin administra-
tion decreased intestinal tissue MDA in the simvas-
tatin-treated group compared to the I/R group.
TNF-a is an inflammatory cytokine that may be
an important mediator in the development of rep-
erfusion-induced tissue injury and lethality [47]. Gre-
wal et al. [15] demonstrated that the treatment of
rats with anti-TNF antibodies could prevent neutro-
phil influx and tissue injury. It is well known that
the serum levels of TNF-a are elevated after intesti-
nal reperfusion and that these pro-inflammatory
cytokine levels reflect mortality [22, 45, 48, 56]. The
biological properties of TNF-a are primarily released
from macrophages during the early phase of an in-
flammatory response, and they stimulate endothe-
lial cells and macrophages to release IL-6 and IL-8
[13, 53]. In the present study, a significant reduc-
tion in the serum TNF-a level was observed 3 hours
after reperfusion in the simvastatin-treated animals.
CONCLUSIONS
The results showed that simvastatin administra-
tion attenuates intestinal I/R injury through inhibi-
tion of TNF-a and MDA production and maintain-
ing intestinal tissue GPx and SOD levels. As simvas-
tatin is a safe drug, it may be used as a protective
therapeutic in attenuating intestinal I/R injury, al-
though more studies should be conducted to un-
derstand the mechanisms involved in this process.
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